5 April 2022 - Curium announced today that its generic version of DaTscan (Ioflupane I 123 injection) was approved on 30 ...
15 March 2022 - Agency supports development of complex generic drug-device combination product to improve competition and access to more affordable ...
7 March 2022 - Teva Pharmaceuticals announced today the launch of a first generic version of Revlimid (lenalidomide capsules), in 5 ...
24 February 2022 - The U.S. FDA has approved the first generic of Apokyn (apomorphine hydrochloride injection) drug cartridges to ...
18 February 2022 - Cost savings from Lenalidomide Sandoz can expand treatment options for patients with haemato-oncology conditions. ...
14 February 2022 - Ensuring high quality, affordable generic drugs are available to the American public. ...
2 February 2022 - The U.S. FDA has approved the first generic of Restasis (cyclosporin ophthalmic emulsion) 0.05% single use vials ...
9 November 2021 - Janet Woodcock, MD, acting commissioner of the FDA, delivered an upbeat report on biosimilars and generics progress ...
28 October 2021 - EMA and the Heads of Medicines Agencies are launching a pilot project to support the repurposing ...
19 October 2021 - Dr. Reddy’s Laboratories today announced the final approval of its abbreviated new drug application for lenalidomide 2.5 ...
2 September 2021 - This week, the FDA reached the milestone of approving more than 100 generic drug applications with a ...
1 September 2021 - Nat-Lenalidomide expands affordable treatment options for patients with multiple myeloma and patients with transfusion-dependent anaemia due to ...
23 June 2021 - The TGA has approved first generic version of Celgene's Pomalyst. ...
22 June 2021 - Acrux is pleased to announce that the US FDA has granted approval of the Company’s generic version ...
19 June 2021 - In the United States, brand-name prescription drugs remain expensive until market exclusivity ends and lower cost generics ...